Omeprazole Market to Grow at CAGR of 5.55% through 2035
Technological advancements in drug delivery and growing
healthcare awareness are expected to drive the Global Omeprazole Market growth
in the forecast period, 2026-2035.
According to TechSci Research report, “Omeprazole
Market – Global Industry Size, Share, Trends, Competition, Forecast &
Opportunities, 2020-2035F”, the Global Omeprazole Market stood at 21.56
Thousand Tonnes in 2024 and is expected to reach 38.65 Thousand Tonnes by 2035
with a CAGR of 5.55% during the forecast period.
Growing healthcare awareness is a critical driver for
the expansion of the global omeprazole market. As more people become educated
about the risks and symptoms of gastrointestinal disorders like GERD, acid
reflux, and peptic ulcers, there is an increasing demand for effective
treatments. This rising awareness is fueled by various channels, including
public health campaigns, digital platforms, healthcare providers, and the
media, all of which emphasize the importance of managing digestive health. The
global shift towards generic medications has played a pivotal role in boosting
the omeprazole market, particularly in cost-sensitive regions. As the patents
for branded omeprazole products expire, a wide range of generic omeprazole
formulations has entered the market, providing consumers with a more affordable
alternative. Generic drugs are typically priced significantly lower than their
branded counterparts, making them an attractive option for patients who require
long-term treatment for conditions like GERD and peptic ulcers.
The rise of generic omeprazole has been particularly
beneficial in emerging markets, where affordability is a major concern for many
individuals seeking treatment. Generic drugs help to improve access to
essential medications, making them available to a broader population. Moreover,
the widespread availability of generic omeprazole has led to increased
competition among pharmaceutical companies, which in turn drives further market
growth. As more healthcare systems around the world adopt cost-effective solutions,
the demand for generic omeprazole will continue to rise, contributing to the
overall expansion of the market. Healthcare providers, especially in
resource-limited settings, often prioritize generic medications due to their
lower cost, which allows for better management of healthcare budgets while
still providing patients with effective treatments. As the generic omeprazole
market expands, the global market for omeprazole as a whole will continue to
experience steady growth.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Omeprazole Market”
The Global Omeprazole Market is segmented into end-use
application, sales channel, regional distribution, and company.
Based on End-Use Application, The Gastroesophageal Reflux Disease (GERD) segment is
anticipated to dominate the Global Omeprazole Market in the forecast period.
GERD is expected to remain the leading application due to the high and growing
prevalence of this chronic condition globally. GERD occurs when stomach acid
frequently backs up into the esophagus, causing symptoms such as heartburn and
chest pain. Omeprazole, as a proton pump inhibitor (PPI), is highly effective
in reducing acid production and alleviating GERD symptoms, which makes it a
preferred treatment option.
The increasing prevalence of GERD, fueled by factors
such as poor dietary habits, high alcohol consumption, smoking, and obesity, is
expected to drive continued demand for omeprazole. Additionally, the chronic
nature of GERD often requires long-term medication, further sustaining demand
for omeprazole. Over-the-counter (OTC) availability of omeprazole will also
contribute to its market dominance, as consumers increasingly seek
self-medication for frequent acid reflux symptoms.
Based on region, Europe region is the second most
dominating in the Global Omeprazole Market, following North America. The high
incidence of gastrointestinal disorders, particularly Gastroesophageal Reflux
Disease (GERD), gastric ulcers, and duodenal ulcers, has driven the demand for
omeprazole across European countries. Much like North America, Europe benefits
from a well-established healthcare system, easy access to pharmaceutical
products, and a high level of awareness regarding treatments for digestive issues.
The widespread availability of omeprazole in both prescription and
over-the-counter (OTC) forms plays a crucial role in its dominance. The
European market also benefits from a large number of patients opting for
self-medication, particularly in countries like Germany and the UK, where OTC
sales are prominent. In addition, the aging population across Europe increases
the demand for treatments addressing chronic conditions such as GERD,
contributing further to the market's growth. Moreover, the European market is
supported by a strong regulatory framework, ensuring the safety and efficacy of
pharmaceuticals like omeprazole. This robust environment has led to a
competitive market with several multinational pharmaceutical companies offering
omeprazole formulations, further increasing availability and accessibility.
Major companies operating in Global Omeprazole Market
are:
- Dr.
Reddy’s Laboratories Inc
- Sandoz
AG
- Perrigo
Company Plc.
- Astrazeneca
Plc
- Amneal
Pharmaceuticals, Inc
- Mylan
N.V.
- Apotex,
Inc.
- Watson
Co., Ltd..
- Santarus
Inc.
Download Free Sample Report
Customers can also request for 10% free customization
on this report
“The increasing use of omeprazole in both pediatric
and geriatric populations is another important trend driving the global market.
In pediatric patients, omeprazole is commonly prescribed to treat conditions
like GERD, reflux esophagitis, and other acid-related disorders. Given its
proven safety and efficacy, omeprazole is often the preferred choice for
pediatric gastroenterologists when treating young patients with these
conditions. As more parents and healthcare providers become aware of
omeprazole's safety profile, its use in children is expected to continue to
grow. In the geriatric population, omeprazole is frequently prescribed for
chronic acid reflux and peptic ulcers, conditions that become more common as
individuals age. The elderly are more susceptible to gastrointestinal issues
due to natural age-related changes in the digestive system, along with the use
of medications that can exacerbate acid reflux. Omeprazole, with its safety and
long-term use potential, is an ideal solution for managing these chronic
conditions in older adults. As the global population continues to age,
particularly in developed nations, the demand for omeprazole in geriatric care
is expected to increase significantly.,” said Mr. Karan Chechi, Research
Director of TechSci Research, a research-based management consulting firm.
“Omeprazole
Market - Global Industry Size, Share, Trends, Opportunity, and Forecast,
Segmented By End-Use Application (Duodenal Ulcer, Gastric Ulcer,
Gastroesophageal Reflux Disease, Erosive Esophagitis, and Others), By Sales
Channel (Direct Sale and Indirect Sale) By Region and Competition, 2020-2035F”, has evaluated the future growth potential of Global
Omeprazole Market and provides statistics & information on market size,
structure and future market growth. The report intends to provide cutting-edge
market intelligence and help decision makers take sound investment decisions.
Besides, the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in Global Omeprazole Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com